Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Ovarian Epithelial Cancer Stage III|Stage IV Ovarian Cancer|Stage IV Breast Cancer
Interventions: DRUG: lapatinib (GW572016)|DRUG: Carboplatin|DRUG: Paclitaxel
Sponsor: Swedish Medical Center
Collaborators: GlaxoSmithKline